The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients

被引：0
|
作者：
Mary Jo Fidler
Cristina L. Fhied
Joanna Roder
Sanjib Basu
Selina Sayidine
Ibtihaj Fughhi
Mark Pool
Marta Batus
Philip Bonomi
Jeffrey A. Borgia
机构：
[1] Sections of Medical Oncology at Rush University Medical Center,Departments of Pathology and Cell & Molecular Medicine
[2] Pathology,undefined
[3] Rush University Medical Center,undefined
[4] Biodesix,undefined
[5] Inc,undefined
[6] Preventative Medicine,undefined
[7] Rush University Medical Center,undefined
[8] Cell and Molecular Medicine at Rush University Medical Center,undefined
[9] Rush University Medical Center,undefined
来源：
BMC Cancer | / 18卷
关键词：
Biomarker; Serum; Non-small cell lung cancer (NSCLC); Erlotinib; Luminex; VeriStrat;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients
    Fidler, Mary Jo
    Fhied, Cristina L.
    Roder, Joanna
    Basu, Sanjib
    Sayidine, Selina
    Fughhi, Ibtihaj
    Pool, Mark
    Batus, Marta
    Bonomi, Philip
    Borgia, Jeffrey A.
    BMC CANCER, 2018, 18
  • [2] The potential role of serum-based pretreatment tests in patients with non-small cell lung cancer treated with nivolumab
    Tagliamento, M.
    Rijavec, E.
    Biello, F.
    Rossi, G.
    Barletta, G.
    Maggioni, C.
    Genova, C.
    Dal Bello, M. G.
    Distefano, R.
    Roder, J.
    Grigorieva, J.
    Oliveira, C.
    Tsypin, M.
    Meyer, K.
    Roder, H.
    Grossi, F.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 163 - 163
  • [3] Improved detection of stage I non-small cell lung cancer with a serum-based assay
    Burt, Bryan M.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2015, 149 (03): : 735 - 736
  • [4] Are preoperative acute phase proteins serum levels associated with clinical outcome in non-small cell lung cancer patients?
    Kasprzyk, Mariusz
    Dyszkiewicz, Wojciech
    Roszak, Magdalena
    Gabryel, Piotr
    Galecki, Bartlomiej
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA-POLISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010, 7 (04) : 415 - 420
  • [5] Prognostic role of the VeriStrat test in first line patients with non-small cell lung cancer treated with platinum-based chemotherapy
    Grossi, Francesco
    Genova, Carlo
    Rijavec, Erika
    Barletta, Giulia
    Biello, Federica
    Dal Bello, Maria Giovanna
    Meyer, Krista
    Roder, Joanna
    Roder, Heinrich
    Grigorieva, Julia
    LUNG CANCER, 2018, 117 : 64 - 69
  • [6] VeriStrat validated in patients with non-small-cell lung cancer
    Butts, Charles A.
    LANCET ONCOLOGY, 2014, 15 (07): : 671 - 672
  • [7] VeriStrat predicts survival in patients with non-small cell lung cancer (NSCLC) treated with erlotinib and bevacizumab
    Salmon, J. S.
    Dang, T. P.
    Billheimer, D.
    Roder, H.
    Grigorieva, J.
    Tsypin, M.
    Herbst, R. S.
    Tsao, A. S.
    Tran, H.
    Carbone, D. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Association of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients
    Zhao, Xueying
    Wang, Shiming
    Wu, Junjie
    Li, Xiaoying
    Wang, Xun
    Gao, Zhiqiang
    Wu, Wenting
    Wang, Haijian
    Wang, Jiucun
    Qian, Ji
    Ma, Ke
    Li, Hui
    Han, Baohui
    Bai, Chunxue
    Li, Qiang
    Liu, Wenbin
    Lu, Daru
    PLOS ONE, 2015, 10 (05):
  • [9] Levels of serum bilirubin in small cell lung cancer and non-small cell lung cancer patients
    Jiang, Da
    Shi, Jian
    Yuan, Meng
    Duan, Xiaoyang
    Li, Lihua
    Li, Qian
    CELLULAR AND MOLECULAR BIOLOGY, 2018, 64 (06) : 71 - 76
  • [10] Peripheral Blood Biomarkers Associated with Clinical Outcome in Non-Small Cell Lung Cancer Patients Treated with Nivolumab
    Tanizaki, Junko
    Haratani, Koji
    Hayashi, Hidetoshi
    Chiba, Yasutaka
    Nakamura, Yasushi
    Yonesaka, Kimio
    Kudo, Keita
    Kaneda, Hiroyasu
    Hasegawa, Yoshikazu
    Tanaka, Kaoru
    Takeda, Masayuki
    Ito, Akihiko
    Nakagawa, Kazuhiko
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (01) : 97 - 105
12345